Adult neural stem cells (NSCs) reside in the subventricular zone (SVZ) and produce neurons throughout life. Although their regenerative potential has kindled much interest, few factors regulating NSCs in vivo are known. Among these is the histone acetyltransferase querkopf (QKF, also known as MYST4, MORF, KAT6B), which is strongly expressed in a small subset of cells in the neurogenic subventricular zone. However, the relationship between Qkf gene expression and the hierarchical levels within the neurogenic lineage is currently unknown. We show here that the 10% of SVZ cells with the highest Qkf expression possess the defining NSC characteristics of multipotency and self-renewal and express markers previously shown to enrich for NSCs. A fraction of cells expressing Qkf at medium to high levels is enriched for multipotent progenitor cells with limited self-renewal, followed by a population containing migrating neuroblasts. Cells low in Qkf promoter activity are predominantly ependymal cells. In addition, we show that mice deficient for Bmi1, a central regulator of NSC self-renewal, show an age-dependent decrease in the strongest Qkf-expressing cell population in the SVZ. Our results show a strong relationship between Qkf promoter activity and stem cell characteristics, and a progressive decrease in Qkf gene activity as lineage commitment and differentiation proceed in vivo.

Adult neural stem cells (NSCs) are present in the subventricular zone (SVZ) and the subgranular layer of the hippocampus and are a source of new neurons throughout life (Zhao et al., 2008). SVZ NSCs give rise to transit amplifying cells, which in turn produce neuroblasts that migrate to the olfactory bulbs and differentiate into olfactory interneurons (Lois et al., 1996). SVZ NSCs have been induced to differentiate into an array of different neural cell types, both in vivo and in vitro (Curtis et al., 2003; Lois and Alvarez-Buylla, 1993). NSCs have therefore aroused great interest, as they hold much promise for the generation of new therapies for neurodegenerative disorders and neural injury. However, two major issues have hindered progress in the field. First, it has been difficult to isolate a pure population of NSCs in their most primitive state. Although some markers are available for the enrichment of NSCs, a definitive marker for NSCs remains to be defined. Second, in order to direct differentiation of NSCs into specific neuronal cell types, which would ideally include cell types not normally formed by NSCs, a greater understanding of factors underlying lineage commitment and hierarchy is required.

NSCs have been shown to express a number of genes including intracellular proteins such as glial fibrillary acidic protein (GFAP), nestin and inhibitor of DNA binding 1 (Id1) (Doetsch et al., 1999; Mignone et al., 2004; Nam and Benezra, 2009), cell surface proteins such as SSEA-1 (also known as FUT4 and LeX) and CD133 (Capela and Temple, 2002; Coskun et al., 2008; Beckervordersandforth et al., 2010), and low levels of heat stable antigen (HSA; HSA is also known as CD24). NSCs also show little affinity for the lectin peanut agglutinin (PNA) (Rietze et al., 2001). Although some of these characteristics have been used to isolate cell fractions enriched for NSCs, most of the markers are expressed strongly in other cells in the brain, whereas others only mark a subset of NSCs. For example, GFAP is expressed by both NSCs and differentiated astrocytes. Of note, none of the markers currently in use to enrich for or to identify NSCs play a non-redundant role in adult NSC biology. We show here that high levels of querkopf (Qkf; also known as Kat6b and Myst4) expression identifies multipotent, self-renewing NSCs.

We have previously shown that a lack of the MYST-family histone acetyltransferase, QKF, leads to defects in the establishment and self-renewal of adult NSCs and consequently to a progressive defect in adult neurogenesis (Merson et al., 2006; Rietze et al., 2001). Remarkably, in humans loss of only one allele of MYST4 (QKF) leads to intellectual disability (Kraft et al., 2011; Clayton-Smith et al., 2011). Unlike other histone acetyltransferases, the expression of Qkf is both spatially and temporally regulated, and strong Qkf expression is localized to neurogenic regions both during development and in the adult (Merson et al., 2006; Thomas et al., 2000). We observed strong expression of Qkf gene in a small subset of neurogenic SVZ cells, raising the question of whether there is a relationship between Qkf gene expression levels and cell identity. Using Qkf–GFP transgenic mice to trace levels of Qkf gene activity, we show that the strongest Qkf–GFP-expressing cells possess all NSC characteristics, namely multipotency and self-renewal. Moreover, we show a remarkable relationship between levels of Qkf–GFP expression and progression in neuronal lineage differentiation.

Characterizing Qkf–GFP reporter expression in transgenic mouse lines

Qkf–GFP bacterial artificial chromosome (BAC) transgenic mice were generated by microinjection of the BAC vector depicted in Fig. 1A into fertilized oocytes. The BAC vector contained an eGFP reporter inserted at the start codon of Qkf in exon 1. In addition, the BAC contained genomic sequence from 67 kb upstream to 130 kb downstream of the Qkf start codon. Offspring of the BAC transgenic founder mice were screened for expression of the GFP reporter between embryonic day (E)9.0 and E12.5. At E9.5 the endogenous Qkf gene and the Qkf–GFP transgene were expressed ubiquitously (supplementary material Fig. S1A,B). A total of 19 independent founder Qkf–GFP reporter lines were generated. The seven strongest GFP-expressing lines were kept for further analysis.

The presence of GFP reporter expression was confirmed by immunohistochemistry on neurospheres from Qkf–GFP transgenic and wild-type littermates. Qkf–GFP transgenic cells attached to a laminin substrate stained strongly for GFP, which was absent in wild-type cells (supplementary material Fig. S1C–F).

To determine the mRNA products of the Qkf–GFP transgene, a northern blot analysis of RNA isolated from the adult brains of all seven Qkf–GFP transgenic lines was performed. Wild-type adult brain RNA and E12.5 RNA were used as controls. Qkf probe no. 19 was used to determine endogenous Qkf levels. This probe hybridizes to the 5′UTR (untranslated region) and to part of the first coding exon of Qkf, both 5′ and 3′ of the GFP insertion site (see Fig. 1A). Consistent with previous studies, Qkf transcripts of 1 kb and 7.2 kb were present in the wild-type adult brain (supplementary material Fig. S1G) (Thomas et al., 2000). The same transcripts were also present at similar levels in the Qkf–GFP adult brains, suggesting that the endogenous Qkf gene was functionally normal. The E12.5 embryo expressed an additional 7.7 kb message, which has been previously observed (Thomas et al., 2000). Using a 668 bp GFP probe, messages between 1.3 kb and 1.8 kb were detected in the Qkf–GFP transgenic, but not in wild-type samples, with a 1.5 kb mRNA being the most prominent. These RNA species were of the expected size: 1079 bp GFP sequence, 113 bp 5′UTR, 35 bp 3′UTR and 50–250 bp poly(A) tail. The 1.5 kb and 1.8 kb messages also hybridized to Qkf probe no.19 because of the presence of Qkf 5′UTR sequence in the GFP mRNAs. In addition, a 1.1 kb transcript was specifically detected by Qkf probe no. 19 in the Qkf–GFP brain RNA. This transcript was not detected by the GFP probe in any wild-type samples. It is therefore likely to be an aberrant splice product of the Qkf–GFP transgene, which does not contain the GFP coding sequence.

The Qkf–GFP transgene activity reflects wild-type Qkf gene expression levels

To determine the accuracy of the Qkf–GFP reporter in representing the wild-type Qkf locus, in situ hybridization was carried out probing for GFP and endogenous Qkf in brain sections from all seven transgenic lines (example shown in Fig. 1B–G). To distinguish wild-type endogenous Qkf from Qkf–GFP transgenic transcripts, a Qkf probe (Qkf 1332) that hybridizes to exon 16, which is absent from the transgene, was used. Endogenous wild-type Qkf mRNA was expressed strongly in the SVZ (Fig. 1B) as previously described (Merson et al., 2006). In particular, a small number of cells within the subependymal layer of the SVZ expressed Qkf at high levels (Fig. 1F). Similarly, in an adjacent slide of the same brain, GFP mRNA was strongly expressed in specific cells (Fig. 1C,G). The complex pattern of Qkf gene expression in the mid-gestation embryo (Thomas et al., 2000) was also faithfully reproduced by the Qkf–GFP transgene, with strong expression domains in the developing telencephalon, eyelids, cornea, retina, the lateral aspects of the lens, nasal epithelium, tongue and developing teeth (supplementary material Fig. S1H–I). Taken together, our results suggest that Qkf–GFP transgene expression accurately depicts endogenous Qkf promoter activity pattern in all seven transgenic lines.

To ensure that Qkf–GFP expression levels quantitatively reflect levels of endogenous wild-type Qkf, cells from E12.5 embryos from three independent transgenic lines were sorted according to their level of GFP expression by fluorescence-activated cell sorting (FACS). After selecting for single live cells and excluding debris (Fig. 1H), four cell fractions were collected on the basis of their Qkf–GFP reporter expression, with the highest 10% Qkf–GFP-positive cells designated Qkf–GFP high (Qkf–GFPHi). The next three fractions containing 30% of cells each were designated Qkf–GFP medium-high (Qkf–GFPMedHi), Qkf–GFP medium-low (Qkf–GFPMedLo), and Qkf–GFP low (Qkf–GFPLo; Fig. 1I). Endogenous Qkf mRNA expression levels were assayed. In all instances examined, Qkf–GFP expression levels correlated strongly with endogenous Qkf expression levels (r=0.9619, P<0.0001, n=3 animals; Fig. 1J–L). On average, Qkf–GFPMedHi cells had 40% less endogenous Qkf expression than Qkf–GFPHi cells (P<0.0001). Similarly, Qkf–GFPHi cells had more than twice the amount of endogenous Qkf expression than Qkf–GFPMedLo, and five-times more Qkf expression than the Qkf–GFPLo population (P<0.0001). This result and the in situ hybridization data demonstrate that the GFP transgene expression under the Qkf promoter accurately portrays endogenous Qkf expression levels.

To determine whether there is a relationship between Qkf promoter activity and neurogenic cell identity in the SVZ, we carried out in vivo cell cycle studies and imaging, ex vivo cell marker analysis, colony formation, self-renewal and differentiation assays. For ex vivo studies, adult Qkf–GFP SVZ cells were sorted according to their level of GFP expression by FACS. As outlined above, after selecting for single live cells and excluding debris (Fig. 1H), four cell fractions were collected on the basis of their Qkf–GFP reporter expression (Fig. 1I).

Subventricular cells with highest Qkf expression exhibit the highest capacity for neurosphere colony formation

Cells sorted from adult Qkf–GFP SVZ of seven transgenic founder lines were assayed for the formation of colonies of proliferating cells (neurospheres) and showed a strong positive correlation between Qkf–GFP expression levels and the ability to form neurospheres (Fig. 2A, data summarized in B; r=0.7800, P<0.0001, two-tailed test). The Qkf–GFPHi fraction gave rise to the highest number of neurospheres, which was significantly more than the three other fractions (P<0.0001, n=28 Qkf–GFP sorts using one animal each). By contrast, neurospheres were rare in cell fractions with the lowest Qkf–GFP expression. A 130-fold enrichment for neurosphere forming cells was observed in the Qkf–GFPHi fraction over the Qkf–GFPLo fraction, a 12-fold enrichment over unsorted cells (P<0.0001, n=28 Qkf–GFP sorts and six unsorted SVZ cultures from one animal each) and a 4.5-fold enrichment over wild-type cells sorted by FACS using the same criteria as those described in Fig. 1H (P<0.0001, n=28 Qkf–GFP sorts, n=3 wild-type sorts). Our data suggest that high Qkf expression correlates with neurogenic activity of SVZ cells. Indeed, the Qkf–GFPHi population was so highly enriched for neurosphere-forming cells that sorting of SVZ cells using a combination of stem cell markers, which individually enrich for neurosphere-forming cells (Qkf–GFPHi, SSEA-1 positive, CD133 positive, HSALo), did not result in further enrichment (data not shown).

Fig. 1.

The Qkf–GFP transgenic mouse strains and the SVZ cell sorting strategy. (A) The construct used to generate Qkf–GFP transgenic mice contained exons −2 to 13 of the Qkf gene and 67 kb of upstream sequence, totalling 197 kb of Qkf genomic sequence. The eGFP coding sequence was inserted in the first coding exon of the Qkf gene on BAC pLD53SCA-E-B. (BG) In situ hybridization shows the overlap between endogenous Qkf and GFP transgene expression in the SVZ. Qkf probe 1332, which hybridizes to a 1.6 kb fragment of exon 16, not present in the Qkf–GFP transgenic vector, shows strong Qkf expression in the SVZ (B). The Qkf–GFP transgene expression (C, dark-field illumination; E, bright-field illumination) closely resembles endogenous Qkf expression in an adjacent slide of the same brain in B. (D) Sense control hybridization. (F,G) High magnification images show strong Qkf and GFP expression in individual subependymal cells of the SVZ. (H,I) FACS sorting strategy to isolate SVZ cell populations with different levels of Qkf promoter activity driving GFP expression. (H) Single cells (i) and live cells (ii; propidium iodide negative) were gated. Debris was excluded on the basis of forward scatter and side scatter (FSC-A, SSC-A, iii). Four cell fractions were collected according to their Qkf–GFP expression levels (I), and used for subsequent experiments. (JL) Endogenous Qkf expression levels in sorted cell populations. Each graph represents one animal and error bars indicate technical variation. For all data combined (J–L; n=3 animals from three independent lines), P<0.0001 for all multi-comparisons. CC, corpus callosum; LV, lateral ventricle; Sp, septum; SVZ, subventricular zone. Scale bars: 173 μm in B–E and 14 μm in F,G.

Fig. 1.

The Qkf–GFP transgenic mouse strains and the SVZ cell sorting strategy. (A) The construct used to generate Qkf–GFP transgenic mice contained exons −2 to 13 of the Qkf gene and 67 kb of upstream sequence, totalling 197 kb of Qkf genomic sequence. The eGFP coding sequence was inserted in the first coding exon of the Qkf gene on BAC pLD53SCA-E-B. (BG) In situ hybridization shows the overlap between endogenous Qkf and GFP transgene expression in the SVZ. Qkf probe 1332, which hybridizes to a 1.6 kb fragment of exon 16, not present in the Qkf–GFP transgenic vector, shows strong Qkf expression in the SVZ (B). The Qkf–GFP transgene expression (C, dark-field illumination; E, bright-field illumination) closely resembles endogenous Qkf expression in an adjacent slide of the same brain in B. (D) Sense control hybridization. (F,G) High magnification images show strong Qkf and GFP expression in individual subependymal cells of the SVZ. (H,I) FACS sorting strategy to isolate SVZ cell populations with different levels of Qkf promoter activity driving GFP expression. (H) Single cells (i) and live cells (ii; propidium iodide negative) were gated. Debris was excluded on the basis of forward scatter and side scatter (FSC-A, SSC-A, iii). Four cell fractions were collected according to their Qkf–GFP expression levels (I), and used for subsequent experiments. (JL) Endogenous Qkf expression levels in sorted cell populations. Each graph represents one animal and error bars indicate technical variation. For all data combined (J–L; n=3 animals from three independent lines), P<0.0001 for all multi-comparisons. CC, corpus callosum; LV, lateral ventricle; Sp, septum; SVZ, subventricular zone. Scale bars: 173 μm in B–E and 14 μm in F,G.

Fig. 2.

High Qkf promoter activity corresponds to a high capacity to form neurosphere colonies. (A) Neurosphere colony formation in the four cell fractions expressing different levels of Qkf–GFP examined in seven independent Qkf–GFP transgenic founder mouse lines. (B) Summarized results of all the lines presented in A. (C) Clonal colony-formation assays. Note the strong positive correlation between Qkf–GFP expression and colony formation. (D) Control neurosphere colony formation assayed in a mouse line expressing GFP under the control of the β-actin promoter. (E) Cell viability of the enzymatically and mechanically dissociated, and FACS sorted SVZ was on average 35% of all sorted events in the four sorted populations. (F) Proportion of live cells forming neurospheres (on the basis of cell viability data in E and supplementary material Fig. S2). Asterisks indicate a significant difference between the marked fraction and Qkf–GFPHi at *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. Circles in D indicate a significant difference between Qkf–GFPLo and Qkf–GFPMedHi or Qkf–GFPMedLo; P<0.01. See supplementary material Tables S1–S6 for multiple comparisons and exact P-values. Data were analyzed as described in the Materials and Methods.

Fig. 2.

High Qkf promoter activity corresponds to a high capacity to form neurosphere colonies. (A) Neurosphere colony formation in the four cell fractions expressing different levels of Qkf–GFP examined in seven independent Qkf–GFP transgenic founder mouse lines. (B) Summarized results of all the lines presented in A. (C) Clonal colony-formation assays. Note the strong positive correlation between Qkf–GFP expression and colony formation. (D) Control neurosphere colony formation assayed in a mouse line expressing GFP under the control of the β-actin promoter. (E) Cell viability of the enzymatically and mechanically dissociated, and FACS sorted SVZ was on average 35% of all sorted events in the four sorted populations. (F) Proportion of live cells forming neurospheres (on the basis of cell viability data in E and supplementary material Fig. S2). Asterisks indicate a significant difference between the marked fraction and Qkf–GFPHi at *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. Circles in D indicate a significant difference between Qkf–GFPLo and Qkf–GFPMedHi or Qkf–GFPMedLo; P<0.01. See supplementary material Tables S1–S6 for multiple comparisons and exact P-values. Data were analyzed as described in the Materials and Methods.

Because plating density can influence the efficiency of neurosphere colony formation (Capela and Temple, 2002), we carried out clonal assays. Cells were sorted as described above, and each sorted event was plated into a well of a 96-well plate. Consistent with bulk culture, a strong, positive correlation between Qkf–GFP expression levels and neurosphere forming ability was observed (r=0.8997, P<0.0001; Fig. 2C). The number of neurosphere forming cells was significantly higher in the Qkf–GFPHi fraction than in all other fractions (P<0.0001, n=3). Therefore, plating densities did not affect the relationship between Qkf–GFP expression levels and neurosphere formation.

To ensure that GFP expression on its own did not affect colony formation, SVZ cells from β-actin–GFP transgenic mice (Hadjantonakis et al., 1998) were sorted as described in Fig. 1H,I and assayed for neurosphere colony formation. Although there was some variation in the colony-forming capacity of SVZ cells expressing different levels of β-actin–GFP, this pattern was distinctly different from that observed in Qkf–GFP mice (Fig. 2D compare with B); no significant correlation was found between β-actin–GFP expression and neurosphere formation (r=0.4532, P=0.140, n=4 β-actin–GFP animals). Therefore, the strong relationship between Qkf–GFP expression levels and neurogenic activity is specific to the regulatory elements of the Qkf gene.

One in four live Qkf–GFPHi subventricular cells give rise to a neurosphere colony

In contrast to sorted blood cells, only a minority of the FACS events derived from the enzymatically and mechanically dissociated SVZ represent live cells. Therefore, we evaluated the relationship between FACS events and the number of viable cells in the different Qkf–GFP fractions immediately after sorting. Approximately 35% of sorted events were found to be live cells (Fig. 2E). The relationship between FACS events and live cells was similar in all Qkf–GFP fractions, except for a slight reduction in the Qkf–GFPLo fraction (supplementary material Table S5; n=4). This suggests that the correlation between Qkf–GFP expression levels and neurosphere formation is not an artefact due to the proportion of live cells in the different Qkf–GFP fractions at the time of plating.

Enrichment in live cells (rather than sorted events) is commonly used as a baseline in other studies (Capela and Temple, 2002; Coskun et al., 2008; Rietze et al., 2001). When based on the number of sorted cells (Fig. 2E) that are alive 2 hours after plating (supplementary material Fig. S2), one in four live cells in the Qkf–GFPHi fraction give rise to neurospheres (Fig. 2F), compared with 1:50 unsorted live cells (P<0.0001, n=28 Qkf–GFP sorts, n=6 unsorted wild-type cultures), showing the high enrichment of neurosphere-forming cells in the Qkf–GFPHi fraction.

High Qkf gene activity indicates self-renewal potential

Self-renewal is one of the defining criteria of stem cells. To determine the relationship between Qkf–GFP expression levels and the self-renewal potential of SVZ neurosphere-forming cells, long-term passaging was carried out as an in vitro readout for self-renewal. Freshly isolated SVZ cells were sorted on the basis of Qkf–GFP expression and plated at equal cell densities. After five passages, only the two highest Qkf–GFP-expressing fractions retained proliferating cells (Fig. 3A; n=6 Qkf–GFP sorts and cultures). Moreover, two Qkf–GFPHi and two Qkf–GFPMedHi cultures were chosen and passaged successfully until passage 12. Importantly, there were nearly 15-fold more cells in the Qkf–GFPHi cultures than in the Qkf–GFPMedHi cultures after five passages, suggesting that a substantial proportion of the Qkf–GFPMedHi colonies were progenitor colonies with limited self-renewal capacity. The two lowest Qkf–GFP fractions did not maintain any self-renewal activity. Even though live cells were present in these fractions at passage one, by the third passage, no proliferating cells were present in the Qkf–GFPLo culture. Similarly, only one out of six Qkf–GFPMedLo cultures was able to proliferate beyond passage four, and no live cells were present in this culture at passage 6. The strong positive correlation between Qkf–GFP expression and self-renewal ability shows that high Qkf levels are indicative of the self-renewal potential of NSCs (r=0.9045, P<0.0001).

Highest Qkf promoter activity indicates the highest proliferative capacity

Neurospheres contain stem cells, transit amplifying cells and lineage-restricted proliferating progeny. In the neurosphere assay, stem cells are thought to have an increased proliferation rate and capacity compared with progenitor cells (Louis et al., 2008; Reynolds and Rietze, 2005). We determined the proliferative capacity of SVZ colony-forming cells by assessing the size of neurospheres in the different Qkf–GFP-expressing fractions.

SVZ cells were sorted on the basis of Qkf–GFP expression and plated in a semi-solid medium containing collagen. Colonies were grown for 3 weeks and then scored. Stem cell colonies are designated as colonies that are larger than 2 mm in diameter three weeks after plating (Fig. 3B). The Qkf–GFPHi fraction formed the highest proportion of stem cell colonies, more than the Qkf–GFPMedHi in trend fraction (P=0.092, n=7) and significantly more than the two lowest Qkf–GFP-expressing fractions (P<0.01), which very rarely formed large colonies (Fig. 3C). Interestingly, one in 3.5 Qkf–GFPHi colonies were larger than 2 mm, suggesting that 29% of neurosphere-forming cells in the Qkf–GFPHi are NSCs. There was a significant, positive correlation between stem cell colony formation and Qkf promoter activity (r=0.8870, P<0.0001).

To determine the proliferation capacity of SVZ cells in bulk neurosphere cultures, the volume of all individual neurospheres in each of the four Qkf–GFP fractions was determined. There was a positive correlation between Qkf–GFP expression levels and the average volume of neurospheres (r=0.3434, P<0.0001; Fig. 3D). Neurospheres in the Qkf–GFPHi fraction were on average, more than twice the size of neurospheres in the two low Qkf–GFP-expressing fractions (P<0.0001, n=583 Qkf–GFPHi scored neurospheres, 546 Qkf–GFPMedHi, 233 Qkf–GFPMedLo, 26 Qkf–GFPLo).

Together, our results show that the cells with the highest Qkf levels have the greatest capacity for neurosphere formation (Fig. 2), long-term self-renewal (Fig. 3A) and a high proliferative capacity (Fig. 3C,D), indicative of stem cell activity. The experiments above indicated that Qkf gene activity traced NSC identity as assessed by ex vivo and in vitro experiments. In the next section, we examined the relationship between Qkf gene activity and NSC identity in vivo.

The slow-cycling neural stem cells have the highest Qkf promoter activity in vivo

The SVZ neurogenic region contains cell types with different cell cycle characteristics. Transit amplifying cells and neuroblasts are thought to divide approximately every 12–18 hours, whereas NSCs divide once every 14–15 days (Craig et al., 1999; Morshead et al., 1998). Cells can be identified by their cell cycle length using both the thymidine analogue BrdU, which is incorporated into cellular DNA during S phase of the cell cycle, and Ki67, which is an endogenous marker for actively proliferating cells in G1, S, G2 or M phase. To mark fast dividing cells (neuroblasts and transit amplifying cells), four BrdU injections were administered over 4 hours, after which the SVZ cells were sorted, spun onto slides and stained for BrdU. Although there was a positive correlation between Qkf promoter activity and the number of short-term BrdU-labelled cells (r=0.6962, P=0.0027; Fig. 3E), the number of cells showing short-term incorporation of BrdU was not significantly different between the three strongest Qkf–GFP-expressing fractions (P<0.15, n=4). Only the Qkf–GFPLo fraction contained significantly fewer cells in S phase than the Qkf–GFPHi and Qkf–GFPMedHi fractions (P=0.0066 and 0.0219). All four fractions contained comparable numbers of Ki67-positive cycling cells (P<0.10, n=3; Fig. 3F). Therefore, fast-cycling cells are present in all four Qkf–GFP fractions.

Fig. 3.

The highest Qkf promoter activity indicates self-renewal, proliferative capacity and cell cycle characteristics of NSCs. (A) Long-term culture and passaging of SVZ neurosphere-forming cells. Note the log scale and that only SVZ cells expressing high levels of Qkf–GFP were able to form neurospheres that could be passaged and cultured for at least 3 months. (B–D) Proliferative capacity of SVZ colony-forming cells assessed by semi-solid neural colony forming assay (B,C) and measuring the size of neurospheres in bulk suspension cultures (D). (E,F) In vivo assessment of short-term BrdU incorporation by cells (E; four BrdU injections over 4 hours) and Ki67-positive cells (F), corresponding predominantly to transit amplifying cells and neuroblasts. (G) In vivo assessment of long-term BrdU incorporation by cells, corresponding to the slow-cycling NSC and terminally differentiated cells (bi-daily BrdU injections for 14 days, followed by 7 days without treatment before FACS analysis). Asterisks indicate a significant difference between the marked fraction and Qkf–GFPHi at *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. See supplementary material Tables S7–S11 for multiple comparisons and exact P-values. Scale bars: 1 mm (B). Data were analyzed as described in the Materials and Methods.

Fig. 3.

The highest Qkf promoter activity indicates self-renewal, proliferative capacity and cell cycle characteristics of NSCs. (A) Long-term culture and passaging of SVZ neurosphere-forming cells. Note the log scale and that only SVZ cells expressing high levels of Qkf–GFP were able to form neurospheres that could be passaged and cultured for at least 3 months. (B–D) Proliferative capacity of SVZ colony-forming cells assessed by semi-solid neural colony forming assay (B,C) and measuring the size of neurospheres in bulk suspension cultures (D). (E,F) In vivo assessment of short-term BrdU incorporation by cells (E; four BrdU injections over 4 hours) and Ki67-positive cells (F), corresponding predominantly to transit amplifying cells and neuroblasts. (G) In vivo assessment of long-term BrdU incorporation by cells, corresponding to the slow-cycling NSC and terminally differentiated cells (bi-daily BrdU injections for 14 days, followed by 7 days without treatment before FACS analysis). Asterisks indicate a significant difference between the marked fraction and Qkf–GFPHi at *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. See supplementary material Tables S7–S11 for multiple comparisons and exact P-values. Scale bars: 1 mm (B). Data were analyzed as described in the Materials and Methods.

To assess the number of the infrequently dividing NSCs, we carried out a long-term BrdU incorporation experiment. Mice were injected twice daily with BrdU for 2 weeks, followed by 1 week without treatment. BrdU is distributed to daughter cells through cell division, and thereby becomes more dilute as cells divide. Therefore, any cells positive for BrdU after 1 week without treatment are slow-dividing or terminally differentiated cells. Following the 3-week BrdU labelling procedure, SVZ cells were sorted on the basis of their Qkf–GFP reporter expression, and stained for BrdU. Approximately 10% of Qkf–GFPHi cells were positive for BrdU, which was significantly more than in the Qkf–GFPMedHi and the Qkf–GFPMedLo fraction (P<0.05, n=3; Fig. 3G). Interestingly, 8% of Qkf–GFPLo cells were also positive for BrdU after the 3-week procedure. However, on the basis of the colony-forming and proliferation assays (Figs 2, 3), these cells lacked the ability to give rise to neurosphere colonies or to divide more than five times in vitro. Therefore, it is probable that the long-term BrdU-incorporating cells in the Qkf–GFPLo fraction were terminally differentiated cells. Remarkably, this shows that the level of Qkf–GFP expression distinguishes between long-term BrdU-labelling NSCs and terminally differentiated cells. In conclusion, the Qkf–GFPHi fraction contains the great majority of slow dividing, self-renewing, neurosphere colony-forming cells, whereas all four Qkf–GFP fractions contain some other type of proliferating cells.

Subventricular cells with the highest Qkf promoter activity express neural stem cell markers

NSCs are widely considered to be astrocyte-like cells in the subependymal layer of the SVZ, which express the mature astrocyte marker GFAP (Doetsch et al., 1999; Garcia et al., 2004; Morshead et al., 2003a). In addition, heat stable antigen (HSA, CD24), which is expressed on the surface of ependymal cells and neuroblasts (Calaora et al., 1996), is expressed at low levels in neurosphere-forming cells (Rietze et al., 2001). This is consistent with the observation that NSCs reside in the subependymal layer of the SVZ (Chiasson et al., 1999; Doetsch et al., 1999; Laywell et al., 2000). SSEA-1 has been used for the enrichment of NSCs from the adult SVZ and embryonic brains. Between 12.5% and 25% of sorted SSEA-1-positive cells form neurospheres (Capela and Temple, 2002; Capela and Temple, 2006). In addition to a GFAP-positive NSC population in the subependymal layer, a smaller, more quiescent population of NSCs expressing CD133 has been reported (Coskun et al., 2008; Beckervordersandforth et al, 2010).

To determine the cellular identity of the four Qkf–GFP fractions, we examined the expression of specific SVZ cell markers either by flow cytometry or by immunofluorescent staining and counting of acutely sorted SVZ cells. There was a strong positive correlation between Qkf–GFP expression and the proportion of GFAP-positive (r=0.7818, P=0.0003, n=4; Fig. 4A), HSALo (r=0.7964, P<0.0001, n=6; Fig. 4B), SSEA-1-positive (r=9079, P<0.0001, n=7; Fig. 4C) and CD133-positive (r=0.7242, P=0.0077, n=3; Fig. 4D) cells. In particular, 65% of sorted events in the Qkf–GFPHi population were positive for GFAP, which was threefold higher than the Qkf–GFPMedHi, and sixfold higher than the Qkf–GFPMedLo and Qkf–GFPLo fractions (P<0.0001; Fig. 4A). Similarly, approximately 80% of sorted events in the Qkf–GFPHi and Qkf–GFPMedHi fractions expressed HSA at low levels, which was significantly more than the two lowest Qkf–GFP fractions (P<0.0001; Fig. 4B). Fifty-five percent of sorted events in the Qkf–GFPHi fraction strongly expressed SSEA-1, which was significantly more than the Qkf–GFPMedHi, Qkf–GFPMedLo and Qkf–GFPLo fractions (Fig. 4C; P<0.0001). We found relatively few CD133-positive cells in the SVZ. However, there was approximately sevenfold enrichment for CD133-positive cells in the Qkf–GFPHi fraction, over the Qkf–GFPMedLo (P=0.0149; Fig. 4D) and Qkf–GFPLo (P=0.0099) fractions. This suggests that high Qkf promoter activity enriches for all cells expressing NSC markers rather than a specific sub-population of stem cells. Altogether, our cell marker analyses show that the SVZ fraction with the highest Qkf–GFP expression is highly enriched for the full range of stem cell markers (GFAP positive, HSALo, SSEA-1 positive and CD133 positive).

To determine which fractions are likely to contain neuroblasts, we utilized polysialylated neural cell adhesion molecule (PSA-NCAM), a polysialylated cell surface protein specifically expressed on neuroblasts (Doetsch et al., 1997). The largest proportion of PSA-NCAM-positive cells was found in the Qkf–GFPMedLo fraction (P<0.005, n=3; Fig. 4E), suggesting that neuroblasts were highly enriched in this Qkf–GFPMedLo population. Interestingly, we observed a high overlap between PSA-NCAM expression levels and nestin staining (Fig. 4F, n=3), an intermediate filament that is widely expressed in the SVZ (Doetsch et al., 1997). Our results suggest that endogenous nestin is most strongly expressed in neuroblasts and weakly in other SVZ cell types.

Ependymal cells are differentiated cells that line the lateral ventricle and provide nutrients for cells within the SVZ NSC niche. While HSA is weakly expressed on the surface of NSCs and progenitor cells, it is strongly expressed on ependymal cells and neuroblasts (Calaora et al., 1996). To determine whether ependymal cells were enriched in any of the Qkf–GFP fractions, we screened for the presence of HSA expression, and absence of PSA-NCAM staining in the four Qkf–GFP populations (see Fig. 4Bii-v for HSAHi population and E for PSA-NCAMHi population). Only 9.8% and 11.5% of Qkf–GFPHi and Qkf–GFPMedHi sorted events, respectively, stained strongly for HSA, which was significantly less than the Qkf–GFPMedLo (53.6%) and Qkf–GFPLo (65.4%) fractions (P<0.0001, n=6; Fig. 4B). Migrating neuroblasts coexpress HSA and PSA-NCAM (Calaora et al., 1996). Because 43% of the sorted events in the Qkf–GFPMedLo fraction were PSA-NCAM positive, it is probable that the majority (43 of 53.6, i.e. 80%) of the HSA-positive cells in this fraction were PSA-NCAM–HSA double positive neuroblasts. By contrast, only a small proportion of FACS sorted events in the Qkf–GFPLo fraction were PSA-NCAM positive (16%), whereas strong HSA staining was common (65.4% of all FACS events). Therefore, HSA-positive, PSA-NCAM-negative ependymal cells are likely to be enriched in the Qkf–GFPLo population.

Altogether, our cell marker analyses suggest that the Qkf–GFPHi fraction contained most of the NSCs, the Qkf–GFPMedHi fraction was enriched for transit amplifying cells, and the Qkf–GFPMedLo fraction mostly contained neuroblasts, whereas the Qkf–GFPLo population was enriched for ependymal cells.

GFAP-positive subventricular zone stem cells express Qkf–GFP at high levels

Our analyses have revealed that the acutely isolated Qkf–GFPHi population was enriched for stem cell markers and was highly enriched for self-renewing neurosphere-colony forming cells. To further investigate the overlap between high Qkf expression and cell identity in vivo, whole-mount staining of SVZ tissue dissected from Qkf–GFP animals was carried out (n=16 animals) as described previously (Mirzadeh et al., 2010; Shen et al., 2008). The results are shown in Fig. 5A and all images depict the anterior-dorsal SVZ in the lateral wall of the lateral ventricle. The ependymal surface of the SVZ was marked using a combination of β-catenin and γ-tubulin as previously described (Mirzadeh et al., 2008). The typical honeycomb architecture of the ependymal surface was observed. A small number of GFAP-positive stem cell processes were intercalated in the ependymal layer (Fig. 5D, arrows). Consistent with cell surface marker studies, there was very little Qkf–GFP expression in the ependymal layer (Fig. 5D). Immediately below the ependymal layer, more GFAP-positive cell processes and a small number of cell bodies were evident (Fig. 5E–H). Sparse Qkf–GFP expression was found to overlap with cell bodies of GFAP-positive cells. Deeper in the subependymal layer (Fig. 5I–T), strong overlap was observed between GFAP-positive stem cells and strong Qkf–GFP-expressing cells (Fig. 5I,J,L,O,P,R). Analysis of ten high-magnification confocal images taken in the anterior-dorsal region of the SVZ (Fig. 5A) across four different animals revealed that 88% of GFAP-positive cells in the subependymal zone (i.e. 44 out of 50) overlapped with strong Qkf–GFP expression (e.g. Fig. 5L,R). This is consistent with flow cytometry data, which showed that 87% of GFAP-positive SVZ cells are found in the Qkf–GFPHi and Qkf–GFPMedHi populations. Similarly, strong SSEA-1 expression was found in 66% (42 out of 64) of GFAP-positive cells (Fig. 5I,K,M,O,Q,S). Remarkably, 94% (n=35) of cells that were double positive for SSEA-1 and GFAP were found to express Qkf–GFP strongly (Fig. 5N). This overlap between strong Qkf–GFP, GFAP and SSEA-1 expression was unique, because GFAP and strong Qkf–GFP expression was not found in ependymal cells (Fig. 5B–D) or in PSA-NCAM-positive neuroblasts (Fig. 5U–W). Together, these data reiterate that strong Qkf expression was largely confined to GFAP- and SSEA-1-double-positive stem cells.

Fig. 4.

Cells of the Qkf–GFPHi fraction express known NSC markers. The markers GFAP (A), HSA (B), SSEA-1 (C), CD133 (D) and PSA-NCAM (E) were analyzed by flow cytometry; (i) quantifications and (ii–v) flow cytometry profiles. (F) Nestin (red) immunofluorescence in cells collected by FACS and cytospun; (i) quantifications and (ii–vii) immunofluorescence images. Asterisks indicate a significant difference between the marked fraction and Qkf–GFPHi at *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001; + symbols in E and F indicate a significant difference between the marked fraction and Qkf–GFPMedLo at ++P<0.01, +++P<0.001, ++++P<0.0001. See supplementary material Tables S12–S17 for multiple comparisons and exact P-values. Data were analyzed as described in the Materials and Methods.

Fig. 4.

Cells of the Qkf–GFPHi fraction express known NSC markers. The markers GFAP (A), HSA (B), SSEA-1 (C), CD133 (D) and PSA-NCAM (E) were analyzed by flow cytometry; (i) quantifications and (ii–v) flow cytometry profiles. (F) Nestin (red) immunofluorescence in cells collected by FACS and cytospun; (i) quantifications and (ii–vii) immunofluorescence images. Asterisks indicate a significant difference between the marked fraction and Qkf–GFPHi at *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001; + symbols in E and F indicate a significant difference between the marked fraction and Qkf–GFPMedLo at ++P<0.01, +++P<0.001, ++++P<0.0001. See supplementary material Tables S12–S17 for multiple comparisons and exact P-values. Data were analyzed as described in the Materials and Methods.

Fig. 5.

GFAP-positive stem cells overlap with strong Qkf–GFP expression in vivo. (A) All confocal images were taken in the anterior–dorsal SVZ region of the lateral wall of the lateral ventricle. (B–D) The honeycomb architecture of the ependymal layer stained with β-catenin and γ-tubulin (both blue) shows little GFAP and Qkf–GFP staining. Some GFAP-positive processes are intercalated in the ependymal layer (red; arrows in D). (E–H) Immediately below the ependymal layer GFAP-positive processes are evident. (I–T) In the subependymal layer, cell bodies of GFAP-positive cells (I, O – cell bodies indicated with arrow) co-express Qkf–GFP and SSEA-1 (L–N and R–T). (U) Overview of PSA-NCAM-positive neuroblast chains surrounded by GFAP-positive processes of NSCs. (V–W) PSA-NCAM-positive neuroblasts shows little overlap with strong Qkf–GFP expression. (X) Wild-type control showing absence of Qkf–GFP expression, and the presence of GFAP-positive cells in the SVZ. Scale bars: 500 μm (A), 20 μm (B–H), 10 μm (I–T), 50 μm (Q), 30 μm (V–W) and 20 μm (X).

Fig. 5.

GFAP-positive stem cells overlap with strong Qkf–GFP expression in vivo. (A) All confocal images were taken in the anterior–dorsal SVZ region of the lateral wall of the lateral ventricle. (B–D) The honeycomb architecture of the ependymal layer stained with β-catenin and γ-tubulin (both blue) shows little GFAP and Qkf–GFP staining. Some GFAP-positive processes are intercalated in the ependymal layer (red; arrows in D). (E–H) Immediately below the ependymal layer GFAP-positive processes are evident. (I–T) In the subependymal layer, cell bodies of GFAP-positive cells (I, O – cell bodies indicated with arrow) co-express Qkf–GFP and SSEA-1 (L–N and R–T). (U) Overview of PSA-NCAM-positive neuroblast chains surrounded by GFAP-positive processes of NSCs. (V–W) PSA-NCAM-positive neuroblasts shows little overlap with strong Qkf–GFP expression. (X) Wild-type control showing absence of Qkf–GFP expression, and the presence of GFAP-positive cells in the SVZ. Scale bars: 500 μm (A), 20 μm (B–H), 10 μm (I–T), 50 μm (Q), 30 μm (V–W) and 20 μm (X).

Subventricular cells with high Qkf gene activity are multipotent

Another defining criterion for stem cells is multipotency, i.e. the ability to give rise to a range of progeny. When induced to differentiate, NSCs give rise to all three major neural cell types, namely neurons, astrocytes and oligodendrocytes. To elucidate the correlation between Qkf–GFP transgene expression and multipotency, SVZ cells were sorted and collected on the basis of their levels of Qkf–GFP expression, grown as neurospheres for 7 days and then allowed to differentiate for 7 days before staining for markers of neurons (βIII-tubulin), oligodendrocytes (O4) and astrocytes (GFAP). At total of 25 to 30 neurospheres were differentiated from each Qkf–GFP fraction from each mouse (SVZ cells were sorted from n=3 animals). The exception was the Qkf–GFPLo fraction, as it rarely gave rise to neurospheres.

Only the Qkf–GFPHi and Qkf–GFPMedHi fractions generated all three neuronal cell types (Fig. 6A–H). Qkf–GFPMedLo neurospheres failed to give rise to oligodendrocytes (Fig. 6I–L), and the Qkf–GFPLo neurospheres only formed astrocytes (Fig. 6M–P). To determine the proportion of Qkf–GFPHi and Qkf–GFPMedHi colonies that were multipotent, individual neurosphere colonies were randomly picked and differentiated separately. Twenty-five of forty-two (60%) Qkf–GFPHi colonies (n=6 animals) were found to be tripotent, eight (19%) were bipotent and nine (21%) only formed astrocytes. This is significantly more than the number of Qkf–GFPMedHi colonies (six out of eighteen, i.e. 33%; P=0.011) that were tripotent. Three out of eighteen (17%) Qkf–GFPMedHi colonies were bipotent, and nine out of eighteen (50%) colonies only formed astrocytes. In short, the majority of Qkf–GFPHi-derived neurospheres were tripotent, whereas the majority of Qkf–GFPMedHi-derived neurospheres were not tripotent. These data suggest that multipotency, as determined using the neurosphere assay, is correlated with high Qkf–GFP expression and thus Qkf serves as a marker for multipotent SVZ cells.

Fig. 6.

High Qkf promoter activity indicates multipotency. (A–P) Sorted SVZ cells cultured as neurospheres for 7 days, then differentiated on a laminin substrate and stained for markers of astrocytes (GFAP, blue), neurons (βIII-tubulin, red) and oligodendrocytes (O4, green). Note that only the two strongest Qkf–GFP-expressing fractions were able to produce all three differentiated progeny (A–H). Qkf–GFPMedLo neurospheres were unable to form oligodendrocytes (I–L), and Qkf–GFPLo neurospheres were only able to differentiate into astrocytes (M–P). Scale bars: 50 μm.

Fig. 6.

High Qkf promoter activity indicates multipotency. (A–P) Sorted SVZ cells cultured as neurospheres for 7 days, then differentiated on a laminin substrate and stained for markers of astrocytes (GFAP, blue), neurons (βIII-tubulin, red) and oligodendrocytes (O4, green). Note that only the two strongest Qkf–GFP-expressing fractions were able to produce all three differentiated progeny (A–H). Qkf–GFPMedLo neurospheres were unable to form oligodendrocytes (I–L), and Qkf–GFPLo neurospheres were only able to differentiate into astrocytes (M–P). Scale bars: 50 μm.

Bmi1 mutant mice show an age-dependent decrease in Qkf–GFP expression

Bmi1, a member of the polycomb group repressive complex, is important for maintaining self-renewing NSCs through inhibition of the Ink4a and Arf locus (Molofsky et al., 2003). Owing to a self-renewal defect, the number of NSCs decreases in Bmi1−/− mice in an age-dependent manner. When Qkf–GFP cell populations were analysed in Bmi1 mutant and wild-type littermates, a reduction in the Qkf–GFPHi population was observed in the Bmi1−/− mice, which declined considerably with age (Fig. 7). This suggests that high Qkf–GFP levels, which mark self-renewing multipotent NSCs, accurately report the time-dependent decrease in NSCs previously described in Bmi1 knockout mice.

In this study, we have utilized Qkf–GFP BAC transgenic mice to examine the expression levels of Qkf in the adult SVZ NSC niche, with respect to stem cell characteristics (summarized in Fig. 8 and supplementary material Table S18).

The definition of a stem cell, as coined by Potten (Potten and Loeffler, 1990), designates stem cells as being (a) undifferentiated, (b) proliferative, (c) self-maintaining (i.e. self-renewing) and (d) able to give rise to a range of functional progeny (i.e. multipotent). Utilizing the neurosphere assay, widely used and accepted as a good test of NSC characteristics (Capela and Temple, 2002; Doetsch et al., 1999; Jensen and Parmar, 2006; Morshead et al., 2003b; Reynolds and Weiss, 1992), we have shown that undifferentiated, proliferative, self-renewing and multipotent cells are largely confined to approximately the 1000–1500 strongest Qkf-expressing cells in the SVZ. In addition, we utilized flow cytometry and confocal microscopy of SVZ whole mounts, to demonstrate that the Qkf–GFPHi fraction was highly enriched for the reported stem cell markers GFAPPos, HSALo, SSEA-1Pos and CD133Pos, and not for markers of ependymal cells or neuroblasts (Capela and Temple, 2002; Coskun et al., 2008; Beckervordersandforth et al, 2010; Garcia et al., 2004; Mirzadeh et al., 2008; Morshead et al., 2003a; Rietze et al., 2001; Shen et al., 2008). Exploiting Bmi1 mutant mice, which have a severe defect in NSC self-renewal (Molofsky et al., 2003), we have shown that there is an age-dependent decline in the Qkf–GFPHi population in the Bmi1−/− mutant mice. Consistent with our conclusion that adult NSCs have the highest requirements for Qkf expression, we have previously shown that QKF is required for normal numbers of adult NSCs (Merson et al., 2006; Rietze et al., 2001), and is essential to promote NSC self-renewal and neuronal differentiation (Merson et al., 2006). We have shown that high level Qkf expression is restricted to the NSCs (and not their cellular neighbours) and that a high-level Qkf expression is essential for long-term self-renewal and multipotency. NSCs are greatly reduced in number in vivo and ex vivo in QKF-deficient animals. Importantly, NSC capacity, which is confined to the strongest QKF-expressing cells, as outlined in this study, declines with age in QKF-deficient animals relative to wild-type controls, consistent with a progressive self-renewal defect in Qkf mutant animals (Merson et al., 2006). Furthermore, neurospheres generated from QKF-deficient animals form fewer neurons than wild-type littermates (Merson et al., 2006), reflecting the lack of neuron production found in Qkf–GFPLo neurospheres in the current study. Accordingly, our data suggest that high Qkf promoter activity within NSCs is required to maintain the essential stem cell characteristics of self-renewal and multipotency.

In addition to all NSC characteristics and markers being confined to the strongest Qkf-expressing cells, our data showed a remarkable relationship between Qkf-promoter activity and cell identity within the NSC niche. Although our data suggest that there are also a number of stem cells in the Qkf–GFPMedHi population, there was enrichment for colony-forming cells with limited self-renewal and proliferative capacity, suggesting that transit amplifying cells are enriched in this Qkf–GFPMedHi fraction. Until recently, transit amplifying cells have been difficult to isolate and distinguish from NSCs using cell surface markers. Utilizing GFAP–GFP mice, Pastrana and co-workers showed that SVZ cells positive for epidermal growth factor (EGF) receptor, negative for HSA (CD24), with low-level expression of GFAP have transit amplifying cell characteristics (Pastrana et al., 2009). Remarkably, we also obtain a high degree of enrichment of transit amplifying cells solely on the basis of medium-high expression of Qkf. Interestingly, nearly half of the sorted cells in the Qkf–GFPMedLo fraction were PSA-NCAM positive, which is a marker for neuroblasts (Doetsch et al., 1997). These cells are proliferating, lineage-restricted neural precursors with limited proliferative capacity that migrate from the SVZ to the olfactory bulbs (Doetsch and Alvarez-Buylla, 1996). Our data show that this Qkf–GFPMedLo fraction also contains the highest percentage of nestin and PSA-NCAM-positive cells, suggesting that migrating, proliferating neuroblasts are enriched in the nestin-positive fraction. While other reports suggest that migrating neuroblasts are indeed nestin positive (Doetsch et al., 1997), NSCs have also been identified as nestin-expressing cells (Reynolds and Weiss, 1992), and various astrocyte subpopulations are reported to express nestin at the highest level within the SVZ neurogenic region (Doetsch et al., 1997). Together with the current study, these data suggest that endogenous nestin is not a unique marker for any specific SVZ subpopulation. Lastly, HSA-positive, PSA-NCAM-negative cells were highly enriched in the Qkf–GFPLo fraction and they are likely to represent the ependymal cell population, which has been reported to be PSA-NCAM negative and HSA high (Calaora et al., 1996). Our data document a unique, proportional relationship between Qkf expression levels and cell identity in the SVZ, where the strongest Qkf-expressing cells show all stem cell characteristics, which are gradually lost along with decreasing Qkf promoter activity. Together with our previous reports on the deficiencies in NSC establishment and self-renewal in the QKF-deficient state, we suggest that QKF serves both as a NSC intrinsic regulator and as a marker of ‘stemness’ – the self-renewal potential and multipotency of SVZ cells.

Fig. 7.

High Qkf–GFP expression decreases in a time-dependent manner on a Bmi1-null background. Wild-type littermate controls and Bmi1 mutants, which show an age-dependent progressive decrease in the Qkf–GFPHi population.

Fig. 7.

High Qkf–GFP expression decreases in a time-dependent manner on a Bmi1-null background. Wild-type littermate controls and Bmi1 mutants, which show an age-dependent progressive decrease in the Qkf–GFPHi population.

Fig. 8.

Schematic summary and interpretation. The central NSC characteristics of neurosphere colony formation, self-renewal ability, multipotency and proliferative capacity strongly correlate with high Qkf promoter activity. Together with cell cycle and cell marker analysis, our data suggest that NSCs are highly enriched in the Qkf–GFPHi fraction, transit amplifying cells in the Qkf–GFPMedHi fraction, neuroblasts in the Qkf–GFPMedLo fraction, and ependymal cells in the lowest Qkf–GFPLo fraction.

Fig. 8.

Schematic summary and interpretation. The central NSC characteristics of neurosphere colony formation, self-renewal ability, multipotency and proliferative capacity strongly correlate with high Qkf promoter activity. Together with cell cycle and cell marker analysis, our data suggest that NSCs are highly enriched in the Qkf–GFPHi fraction, transit amplifying cells in the Qkf–GFPMedHi fraction, neuroblasts in the Qkf–GFPMedLo fraction, and ependymal cells in the lowest Qkf–GFPLo fraction.

Interestingly, when Qkf–GFP expression was assayed in a Bmi1-null background, a significant decrease in the Qkf–GFPHi population was observed. Self-renewing multipotent NSCs decrease in an age-dependent manner in Bmi1 mutant mice because of defects in self-renewal (Molofsky et al., 2003). Given that the Qkf–GFPHi population decreased in Bmi1 mutant mice compared with littermate controls as mice aged, this finding supports our hypothesis that Qkf–GFP expression marks and positively correlates with self-renewing and multipotent SVZ cells. In addition, this experiment suggests that Qkf–GFP transgenic mice can be used to screen a large number of mice for potential defects in NSC self-renewal or multipotency in vivo.

QKF is part of the MYST family of histone acetyltransferases. These epigenetic regulators have an essential function in the control of gene expression through their ability to acetylate histones and modify chromatin structure (Thomas and Voss, 2007; Wang et al., 2009). QKF has an identical domain structure to monocytic leukaemia zinc finger protein (MOZ), and all protein domains are highly conserved between these two transcriptional regulators (Voss and Thomas, 2009). Furthermore, the amino acid sequence within the domains is highly similar. We and others have shown that MOZ has an essential function in the maintenance of haematopoietic stem cells (Katsumoto et al., 2006; Thomas et al., 2006). More recently, it has been shown that the role of MOZ in haematopoietic stem cells is dependent on its histone acetyltransferase activity (Perez-Campo et al., 2009), directly demonstrating the importance of chromatin regulation by this subclass of histone acetyltransferases in stem cells. MOZ was originally identified in recurrent translocations leading to acute myeloid leukaemia (Borrow et al., 1996). Several different chromosomal translocations causing leukaemia target the MOZ gene (Aguiar et al., 1997; Carapeti et al., 1998; Chaffanet et al., 2000; Chaffanet et al., 1999; Esteyries et al., 2008; Imamura et al., 2003; Kitabayashi et al., 2001; Rozman et al., 2004), and indeed, translocations targeting the human homologue of Qkf (MYST4/KAT6b) also cause leukaemia (Panagopoulos et al., 2001; Vizmanos et al., 2003). By contrast, deficiency in QKF (MYST4/MORF) leads to intellectual disability in humans (Kraft et al., 2011) and brain developmental defects in mice (Thomas et al., 2000). Taken together, these studies show that QKF is a potent regulator of stem-cell characteristics, where loss of function causes brain developmental defects, and gain of function causes malignancy.

Although we are only beginning to understand the role of chromatin structure in establishing and maintaining stem cells, recent studies have demonstrated that stem cell chromatin is unique and actively modified as stem cells differentiate (Bernstein et al., 2006; Mikkelsen et al., 2007). The role of histone acetylation has been studied in embryonic stem cells. Recently, Ware and co-workers have shown that the histone deacetylase inhibitor sodium butyrate was able to maintain self-renewing mouse and human embryonic stem cells without feeder layers or exogenous factors, highlighting the importance of histone acetylation in maintaining a stem cell state (Ware et al., 2009). Interestingly, we have recently shown that the QKF-related protein MOZ is a key regulator of Hox gene expression in vivo. MOZ is required to maintain the correct levels of histone 3 lysine 9 (H3K9) acetylation at Hox loci during development, and a reduction in MOZ levels leads to aberrant and reduced Hox gene expression and an extensive anterior homeotic transformation of the nervous system and the axial skeleton (Voss et al., 2009). The role of H3K9 acetylation in maintaining chromatin structure extends to NSCs. When oligodendrocyte precursors were redirected to become NSC-like self-renewing multipotent cells, the methylated H3K9 was converted to acetylated H3K9 at the promoter of Sox2 (Kondo and Raff, 2004), a gene essential for maintaining NSCs (Graham et al., 2003). Our data presented here, together with our previous results showing that Qkf mutant mice have severe and progressive defects in adult neurogenesis, suggests that QKF plays a central role in regulating histone acetylation at important stem cell loci within SVZ NSCs.

In conclusion, we have shown that it is possible to isolate the four major populations of the SVZ neurogenic zone, i.e. NSCs, transit amplifying cells, neuroblasts and ependymal cells, on the basis of Qkf promoter activity levels. This system will allow the characterization of neural lineage characteristics including the epigenetic mechanisms that regulate NSC self-renewal and lineage commitment in adult neurogenesis.

Generation of Qkf–GFP transgenic mice

The Qkf–GFP BAC construct used for the generation of transgenic mice was generated by homologous recombination in Escherichia coli using the method described by Gong et. al. (Gong et al., 2002). The eGFP coding sequence with its Kozak sequence and poly adenylation signal from pLD53SCA-E-B (a gift from Nathaniel Heintz, Rockefeller University, New York, USA) were inserted into the first coding exon of the Qkf gene on BAC clone RP23-121O15 replacing the Qkf Kozak sequence and start codon. Experiments were performed on male mice aged between 7 and 12 weeks, and conformed to the regulations set by the Australian NHMRC and the Royal Melbourne Hospital Research Foundation. Transgenic mouse lines were maintained as heterozygous for the Qkf–GFP transgene and genotyped by the presence of GFP expression in tail biopsies.

Northern Blot analysis, in situ hybridization and RT-qPCR

In situ hybridization was carried out with 35S-labelled dCTP (Amersham) using a method described previously (Thomas et al., 2000). Northern blot analysis was performed using standard molecular biology techniques. Qkf probe no. 19 hybridizes to bases 41–1246 of sequence GenBank accession number AF222800, Qkf probe no. 1332 to bases 4019–5633 of AF222800, and the GFP probe to bases 613–1276 of sequence U55763. To determine endogenous Qkf levels in sorted populations, oligonucleotides forward (F) 5′-GCGAATCTCTATGGGTAACG-3′ and reverse (R) 5′-GCACTGCTTCAAGAATCCAC-3′ amplifying from the 5′UTR to exon 1 were used. Expression levels were standardized to 18S (F5′-TCGGAACTGAGGCCATGATT-3′, R5′-CCTCCGACTTTCGTTCTTGATT-3′), Hsp90ab1 (F5′-CCTCCGACTTTCGTTCTTGATT-3′, R5′-AGAATCCGACACCAAACTGC-3′) and Gapdh (F5′-TTCACCACCATGGAGAAGGC-3′, R5′-CCCTTTTGGCTCCACCCT-3′).

FACS and neurosphere culture

SVZ from Qkf–GFP transgenic mice were dissected and enzymatically dissociated using pancreatin–trypsin (2.5% pancreatin, 0.5% trypsin). The tissue was mechanically dissociated using a P200 Gilson pipette. Cells were immediately washed in 0.2% BSA in mouse tonicity (MT-)PBS, passed through a 40 μm sieve (Falcon) and collected by centrifugation. Cells were resuspended in 200–300 μl 0.2% BSA in MT-PBS containing 1 μg/ml propidium iodide (Sigma P-4170) to label dead cells. Cells were sorted into four fractions on the basis of their GFP reporter expression using the FACS DiVA (BD Biosciences) and collected in 2 ml 0.2% BSA in MT-PBS. After collection by brief centrifugation, cells from each of the four Qkf–GFP fractions were suspended in 5 ml NSC proliferation medium [medium described previously (Merson et al., 2006; Voss et al., 2006)] in a 3.5 cm dish. Neurospheres were counted 3–4 days after sorting. For clonal assays, cells were sorted at a density of one event per well of a 96-well plate containing 150 μl NSC proliferation medium, and counted 7 days after plating.

For passaging, neurospheres were collected by brief centrifugation (7 minutes, 120 g), dissociated mechanically using a P1000 Gilson pipette in approximately 900 μl fresh proliferation medium. Dissociated cells were counted using a haemocytometer and plated at a density of 15,000–30,000 cells per cm2 depending on the number of cells available, as described previously (Merson et al., 2006; Voss et al., 2006).

To determine lineage potential, Qkf–GFP SVZ cells were sorted and cultured as neurospheres for 7 days. After 1 week in culture, 25–30 neurospheres from each Qkf–GFP fraction were induced to differentiate on laminin-treated coverslips in differentiation medium as previously described (Merson et al., 2006). To determine the lineage potential of individual neurospheres, colonies were picked and plated individually in a 24-well plate. Neurosphere cells were allowed to differentiate for 1 week, washed, fixed in 4% paraformaldehyde, blocked in 10% normal goat serum, and stained for astrocytes (GFAP; Dako Z0334; 1:500), oligodendrocytes (O4; MAB345; 1:500) and neurons (βIII-tubulin; Promega G7121; 1:2000).

For cell surface marker analysis, SVZ cells were prepared for flow cytometry and stained with antibodies raised against GFAP (Chemicon MAB3402; 1:500), HSA (mCD24-PE conjugated; Vector B-1075; 1:200), SSEA-1 (BD Biosciences no. 347420; 1:20), CD133 (APC conjugated; eBioscience no. 17-1331-81; 1:1000) and PSA-NCAM (AbCys AbC0019; 1:400). Alexa Fluor 633 and APC-conjugated anti-mouse IgM and IgG antibodies were used where required. Cells were sorted on the FACS LSR II (BD Biosciences). Sorts were analyzed using FlowJo v8.7 software.

Immunohistochemistry

Whole-mount SVZ staining was carried out as described previously (Mirzadeh et al., 2010). Briefly, Qkf–GFP animals were perfusion fixed. The SVZ was dissected and fixed overnight at 4°C in 4% paraformaldehyde. After washing and blocking, the SVZ was incubated with primary antibodies against GFP [using an antibody that was conjugated to biotin (Invitrogen A10263)], GFAP, SSEA-1, PSA-NCAM, β-catenin (Sigma-Aldrich C2206; 1:1000) and γ-tubulin (Sigma-Aldrich T5192; 1:1000) for 48 hours at 4°C. After washing, Alexa Fluor secondary antibodies raised against mouse IgG, IgM and rabbit IgG (Invitrogen Alexa Fluor 633 goat anti-mouse IgG A21052; Alexa Fluor 546 goat anti-rabbit IgG A11035; Alexa Fluor 546 goat anti-mouse IgM A21045; used at 1:500) and FITC–streptavidin (Invitrogen SA1001; 1:500) were applied for 48 hours. Samples were washed, mounted and imaged on the Leica SP2 laser scanning microscope system. Images were processed using the IMARIS v7.2 software.

For BrdU (BioScience Products 010198; 1:10), Ki67 (Novocastra NCL-Ki67p; 1:400) and nestin (Chemicon MAB353; 1:200) staining of SVZ cells collected by FACS, cells were cytospun onto gelatine-coated slides and immunostained as described previously (Voss et al., 2006). Cells were counted and photographed using a compound microscope (Axioplan 2, Zeiss).

Cell viability assays

Cells were collected by centrifugation and suspended in 40 μl 0.2% BSA in MT-PBS. Trypan Blue (10 μl, Sigma) was added, mixed, and 10 μl of the cell suspension was added to each of four areas of a haemocytometer and counted.

Neurosphere proliferation assays

SVZ cells from Qkf–GFP animals were sorted as described above. For the neural colony-forming cell assay, cells were suspended in collagen and grown according to manufacturer's instructions (Stemcell Technologies, Vancouver, Canada). Colonies were scored 3 weeks after plating. To determine neurosphere size in bulk cultures, neurospheres were grown for 4 days, after which the size of each neurosphere in each of the Qkf–GFP fractions was determined using a scale in the eyepiece of an inverted microscope (10×objective, 10 × magnification) converted to metric scale using a haemocytometer.

Statistical analysis

Statistical analyses were performed using StatView v5.0 and Intercooled Stata v10. Data are presented as means ± s.e.m. and were analyzed using one or two-factorial analysis of variance (ANOVA) with Qkf–GFP expression levels with or without the specific transgenic founder mouse line or the culture passage number as the independent factors followed by Fisher's or Bonferroni's post-hoc test. Pearson's regression analysis was carried out where appropriate, followed by a two-tailed t-test.

We thank C. Gatt, M. Becroft, T. McLennan, N. Downer and the WEHI FACS and Imaging laboratories for excellent technical support. We are grateful for the gift of the eGFP plasmid pLD53SCA-E-B from N. Heintz, for the β-actin–GFP transgenic mice from A. Nagy and the Bmi1 mutant mice from M. van Lohuizen.

Funding

This work was supported by the Australian National Health and Medical Research Council (to T.T. and A.K.V.: project grants, senior research fellowships, Government IRIISS; to B.N.S.: scholarship), the Australian Stem Cell Centre (to T.T. and A.K.V.: program module; to B.N.S.: scholarship), as well as by the Victorian Government through infrastructure support.

Aguiar
R. C.
,
Chase
A.
,
Coulthard
S.
,
Macdonald
D. H.
,
Carapeti
M.
,
Reiter
A.
,
Sohal
J.
,
Lennard
A.
,
Goldman
J. M.
,
Cross
N. C.
(
1997
).
Abnormalities of chromosome band 8p11 in leukemia: two clinical syndromes can be distinguished on the basis of MOZ involvement
.
Blood
90
,
3130
-
3135
.
Beckervordersandforth
R.
,
Tripathi
P.
,
Ninkovic
J.
,
Bayam
E.
,
Lepier
A.
,
Stempfhuber
B.
,
Kirchhoff
F.
,
Hirrlinger
J.
,
Haslinger
A.
,
Lie
D. C.
, et al. 
. (
2010
).
In vivo fate mapping and expression analysis reveals molecular hallmarks of prospectively isolated adult neural stem cells
.
Cell Stem Cell.
7
,
744
-
758
.
Bernstein
B. E.
,
Mikkelsen
T. S.
,
Xie
X.
,
Kamal
M.
,
Huebert
D. J.
,
Cuff
J.
,
Fry
B.
,
Meissner
A.
,
Wernig
M.
,
Plath
K.
, et al. 
. (
2006
).
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
.
Cell
125
,
315
-
326
.
Borrow
J.
,
Stanton
V. P.
Jr
,
Andresen
J. M.
,
Becher
R.
,
Behm
F. G.
,
Chaganti
R. S.
,
Civin
C. I.
,
Disteche
C.
,
Dube
I.
,
Frischauf
A. M.
, et al. 
. (
1996
).
The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein
.
Nat. Genet.
14
,
33
-
41
.
Calaora
V.
,
Chazal
G.
,
Nielsen
P. J.
,
Rougon
G.
,
Moreau
H.
(
1996
).
mCD24 expression in the developing mouse brain and in zones of secondary neurogenesis in the adult
.
Neuroscience
73
,
581
-
594
.
Capela
A.
,
Temple
S.
(
2002
).
LeX/ssea-1 is expressed by adult mouse CNS stem cells, identifying them as nonependymal
.
Neuron
35
,
865
-
875
.
Capela
A.
,
Temple
S.
(
2006
).
LeX is expressed by principle progenitor cells in the embryonic nervous system, is secreted into their environment and binds Wnt-1
.
Dev. Biol.
291
,
300
-
313
.
Carapeti
M.
,
Aguiar
R. C.
,
Goldman
J. M.
,
Cross
N. C.
(
1998
).
A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia
.
Blood
91
,
3127
-
3133
.
Chaffanet
M.
,
Mozziconacci
M. J.
,
Fernandez
F.
,
Sainty
D.
,
Lafage-Pochitaloff
M.
,
Birnbaum
D.
,
Pebusque
M. J.
(
1999
).
A case of inv(8)(p11q24) associated with acute myeloid leukemia involves the MOZ and CBP genes in a masked t(8;16)
.
Genes Chromosomes Cancer
26
,
161
-
165
.
Chaffanet
M.
,
Gressin
L.
,
Preudhomme
C.
,
Soenen-Cornu
V.
,
Birnbaum
D.
,
Pebusque
M. J.
(
2000
).
MOZ is fused to p300 in an acute monocytic leukemia with t(8;22)
.
Genes Chromosomes Cancer
28
,
138
-
144
.
Chiasson
B. J.
,
Tropepe
V.
,
Morshead
C.
,
van der Kooy
D.
(
1999
).
Adult mammalian forebrain ependymal and subependymal cells demonstrate proliferative potential, but only subependymal cells have neural stem cell characteristics
.
J. Neurosci.
19
,
4462
-
4471
.
Clayton-Smith
J.
,
O'Sullivan
J.
,
Daly
S.
,
Bhaskar
S.
,
Day
R.
,
Anderson
B.
,
Voss
A. K.
,
Thomas
T.
,
Biesecker
L. G.
,
Smith
P.
, et al. 
. (
2011
).
Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the Say-Barber-Biesecker variant of Ohdo syndrome
.
Am. J. Hum. Genet.
89
,
675
-
681
.
Coskun
V.
,
Wu
H.
,
Blanchi
B.
,
Tsao
S.
,
Kim
K.
,
Zhao
J.
,
Biancotti
J. C.
,
Hutnick
L.
,
Krueger
R. C.
Jr
,
Fan
G.
, et al. 
. (
2008
).
CD133+ neural stem cells in the ependyma of mammalian postnatal forebrain
.
Proc. Natl. Acad. Sci. USA
105
,
1026
-
1031
.
Craig
C. G.
,
D'sa
R.
,
Morshead
C. M.
,
Roach
A.
,
van der Kooy
D.
(
1999
).
Migrational analysis of the constitutively proliferating subependyma population in adult mouse forebrain
.
Neuroscience
93
,
1197
-
1206
.
Curtis
M. A.
,
Penney
E. B.
,
Pearson
A. G.
,
van Roon-Mom
W. M.
,
Butterworth
N. J.
,
Dragunow
M.
,
Connor
B.
,
Faull
R. L.
(
2003
).
Increased cell proliferation and neurogenesis in the adult human Huntington's disease brain
.
Proc. Natl. Acad. Sci. USA
100
,
9023
-
9027
.
Doetsch
F.
,
Alvarez-Buylla
A.
(
1996
).
Network of tangential pathways for neuronal migration in adult mammalian brain
.
Proc. Natl. Acad. Sci. USA
93
,
14895
-
1900
.
Doetsch
F.
,
Garcia-Verdugo
J. M.
,
Alvarez-Buylla
A.
(
1997
).
Cellular composition and three-dimensional organization of the subventricular germinal zone in the adult mammalian brain
.
J. Neurosci.
17
,
5046
-
5061
.
Doetsch
F.
,
Caille
I.
,
Lim
D. A.
,
Garcia-Verdugo
J. M.
,
Alvarez-Buylla
A.
(
1999
).
Subventricular zone astrocytes are neural stem cells in the adult mammalian brain
.
Cell
97
,
703
-
716
.
Esteyries
S.
,
Perot
C.
,
Adelaide
J.
,
Imbert
M.
,
Lagarde
A.
,
Pautas
C.
,
Olschwang
S.
,
Birnbaum
D.
,
Chaffanet
M.
,
Mozziconacci
M. J.
(
2008
).
NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia
.
Leukemia
22
,
663
-
665
.
Garcia
A. D.
,
Doan
N. B.
,
Imura
T.
,
Bush
T. G.
,
Sofroniew
M. V.
(
2004
).
GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain
.
Nat. Neurosci.
7
,
1233
-
1241
.
Gong
S.
,
Yang
X. W.
,
Li
C.
,
Heintz
N.
(
2002
).
Highly efficient modification of bacterial artificial chromosomes (BACs) using novel shuttle vectors containing the R6Kgamma origin of replication
.
Genome Res.
12
,
1992
-
1998
.
Graham
V.
,
Khudyakov
J.
,
Ellis
P.
,
Pevny
L.
(
2003
).
SOX2 functions to maintain neural progenitor identity
.
Neuron
39
,
749
-
765
.
Hadjantonakis
A. K.
,
Gertsenstein
M.
,
Ikawa
M.
,
Okabe
M.
,
Nagy
A.
(
1998
).
Generating green fluorescent mice by germline transmission of green fluorescent ES cells
.
Mech. Dev.
76
,
79
-
90
.
Imamura
T.
,
Kakazu
N.
,
Hibi
S.
,
Morimoto
A.
,
Fukushima
Y.
,
Ijuin
I.
,
Hada
S.
,
Kitabayashi
I.
,
Abe
T.
,
Imashuku
S.
(
2003
).
Rearrangement of the MOZ gene in pediatric therapy-related myelodysplastic syndrome with a novel chromosomal translocation t(2;8)(p23;p11)
.
Genes Chromosomes Cancer
36
,
413
-
419
.
Jensen
J. B.
,
Parmar
M.
(
2006
).
Strengths and limitations of the neurosphere culture system
.
Mol. Neurobiol.
34
,
153
-
161
.
Katsumoto
T.
,
Aikawa
Y.
,
Iwama
A.
,
Ueda
S.
,
Ichikawa
H.
,
Ochiya
T.
,
Kitabayashi
I.
(
2006
).
MOZ is essential for maintenance of hematopoietic stem cells
.
Genes Dev.
20
,
1321
-
1330
.
Kitabayashi
I.
,
Aikawa
Y.
,
Yokoyama
A.
,
Hosoda
F.
,
Nagai
M.
,
Kakazu
N.
,
Abe
T.
,
Ohki
M.
(
2001
).
Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation
.
Leukemia
15
,
89
-
94
.
Kondo
T.
,
Raff
M.
(
2004
).
Chromatin remodeling and histone modification in the conversion of oligodendrocyte precursors to neural stem cells
.
Genes Dev.
18
,
2963
-
2972
.
Kraft
M.
,
Cirstea
I. C.
,
Voss
A. K.
,
Thomas
T.
,
Goehring
I.
,
Sheikh
B.
,
Gordon
L.
,
Scott
H.
,
Smyth
G.
,
Ahmadian
M. R.
, et al. 
. (
2011
).
Disruption of the histone acetyltransferase MYST4 leads to a Noonan syndrome-like phenotype and hyperactivated MAPK signaling
.
J. Clin. Invest.
121
,
3479
-
3491
.
Laywell
E. D.
,
Rakic
P.
,
Kukekov
V. G.
,
Holland
E. C.
,
Steindler
D. A.
(
2000
).
Identification of a multipotent astrocytic stem cell in the immature and adult mouse brain
.
Proc. Natl. Acad. Sci. USA
97
,
13883
-
13888
.
Lois
C.
,
Alvarez-Buylla
A.
(
1993
).
Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia
.
Proc. Natl. Acad. Sci. USA
90
,
2074
-
2077
.
Lois
C.
,
Garcia-Verdugo
J. M.
,
Alvarez-Buylla
A.
(
1996
).
Chain migration of neuronal precursors
.
Science
271
,
978
-
981
.
Louis
S. A.
,
Rietze
R. L.
,
Deleyrolle
L.
,
Wagey
R. E.
,
Thomas
T. E.
,
Eaves
A. C.
,
Reynolds
B. A.
(
2008
).
Enumeration of neural stem and progenitor cells in the neural colony-forming cell assay
.
Stem Cells
26
,
988
-
996
.
Merson
T. D.
,
Dixon
M. P.
,
Collin
C.
,
Rietze
R. L.
,
Bartlett
P. F.
,
Thomas
T.
,
Voss
A. K.
(
2006
).
The transcriptional coactivator Querkopf controls adult neurogenesis
.
J. Neurosci.
26
,
11359
-
11370
.
Mignone
J. L.
,
Kukekov
V.
,
Chiang
A. S.
,
Steindler
D.
,
Enikolopov
G.
(
2004
).
Neural stem and progenitor cells in nestin-GFP transgenic mice
.
J. Comp. Neurol.
469
,
311
-
324
.
Mikkelsen
T. S.
,
Ku
M.
,
Jaffe
D. B.
,
Issac
B.
,
Lieberman
E.
,
Giannoukos
G.
,
Alvarez
P.
,
Brockman
W.
,
Kim
T. K.
,
Koche
R. P.
, et al. 
. (
2007
).
Genome-wide maps of chromatin state in pluripotent and lineage-committed cells
.
Nature
448
,
553
-
560
.
Mirzadeh
Z.
,
Merkle
F. T.
,
Soriano-Navarro
M.
,
Garcia-Verdugo
J. M.
,
Alvarez-Buylla
A.
(
2008
).
Neural stem cells confer unique pinwheel architecture to the ventricular surface in neurogenic regions of the adult brain
.
Cell Stem Cell
3
,
265
-
278
.
Mirzadeh
Z.
,
Doetsch
F.
,
Sawamoto
K.
,
Wichterle
H.
,
Alvarez-Buylla
A.
(
2010
).
The subventricular zone en-face: wholemount staining and ependymal flow
.
J. Vis. Exp.
6
,
1938
.
Molofsky
A. V.
,
Pardal
R.
,
Iwashita
T.
,
Park
I. K.
,
Clarke
M. F.
,
Morrison
S. J.
(
2003
).
Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation
.
Nature
425
,
962
-
967
.
Morshead
C. M.
,
Craig
C. G.
,
van der Kooy
D.
(
1998
).
In vivo clonal analyses reveal the properties of endogenous neural stem cell proliferation in the adult mammalian forebrain
.
Development
125
,
2251
-
2261
.
Morshead
C. M.
,
Garcia
A. D.
,
Sofroniew
M. V.
,
van der Kooy
D.
(
2003a
).
The ablation of glial fibrillary acidic protien-positive cells from the adult central nervous system results in the loss of forebrain neural stem cells but not retinal stem cells
.
Eur. J. Neurosc.
18
,
76
-
84
.
Morshead
C. M.
,
Garcia
A. D.
,
Sofroniew
M. V.
,
van Der Kooy
D.
(
2003b
).
The ablation of glial fibrillary acidic protein-positive cells from the adult central nervous system results in the loss of forebrain neural stem cells but not retinal stem cells
.
Eur J. Neurosci.
18
,
76
-
84
.
Nam
H. S.
,
Benezra
R.
(
2009
).
High levels of Id1 expression define B1 type adult neural stem cells
.
Cell Stem Cell
5
,
515
-
526
.
Panagopoulos
I.
,
Fioretos
T.
,
Isaksson
M.
,
Samuelsson
U.
,
Billstrom
R.
,
Strombeck
B.
,
Mitelman
F.
,
Johansson
B.
(
2001
).
Fusion of the MORF and CBP genes in acute myeloid leukemia with the t(10;16)(q22;p13)
.
Hum. Mol. Genet.
10
,
395
-
404
.
Pastrana
E.
,
Cheng
L. C.
,
Doetsch
F.
(
2009
).
Simultaneous prospective purification of adult subventricular zone neural stem cells and their progeny
.
Proc. Natl. Acad. Sci. USA
106
,
6387
-
6392
.
Perez-Campo
F. M.
,
Borrow
J.
,
Kouskoff
V.
,
Lacaud
G.
(
2009
).
The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors
.
Blood
113
,
4866
-
4874
.
Potten
C. S.
,
Loeffler
M.
(
1990
).
Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt
.
Development
110
,
1001
-
1020
.
Reynolds
B. A.
,
Weiss
S.
(
1992
).
Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system
.
Science
255
,
1707
-
1710
.
Reynolds
B. A.
,
Rietze
R. L.
(
2005
).
Neural stem cells and neurospheres – re-evaluating the relationship
.
Nat. Methods
2
,
333
-
336
.
Rietze
R. L.
,
Valcanis
H.
,
Brooker
G. F.
,
Thomas
T.
,
Voss
A. K.
,
Bartlett
P. F.
(
2001
).
Purification of a pluripotent neural stem cell from the adult mouse brain
.
Nature
412
,
736
-
739
.
Rozman
M.
,
Camos
M.
,
Colomer
D.
,
Villamor
N.
,
Esteve
J.
,
Costa
D.
,
Carrio
A.
,
Aymerich
M.
,
Aguilar
J. L.
,
Domingo
A.
, et al. 
. (
2004
).
Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation
.
Genes Chromosomes Cancer
40
,
140
-
145
.
Shen
Q.
,
Wang
Y.
,
Kokovay
E.
,
Lin
G.
,
Chuang
S. M.
,
Goderie
S. K.
,
Roysam
B.
,
Temple
S.
(
2008
).
Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions
.
Cell Stem Cell
3
,
289
-
300
.
Thomas
T.
,
Voss
A. K.
(
2007
).
The diverse biological roles of MYST histone acetyltransferase family proteins
.
Cell Cycle
6
,
696
-
704
.
Thomas
T.
,
Voss
A. K.
,
Chowdhury
K.
,
Gruss
P.
(
2000
).
Querkopf, a MYST family histone acetyltransferase, is required for normal cerebral cortex development
.
Development
127
,
2537
-
2348
.
Thomas
T.
,
Corcoran
L. M.
,
Gugasyan
R.
,
Dixon
M. P.
,
Brodnicki
T.
,
Nutt
S. L.
,
Metcalf
D.
,
Voss
A. K.
(
2006
).
Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells
.
Genes Dev.
20
,
1175
-
1186
.
Vizmanos
J. L.
,
Larrayoz
M. J.
,
Lahortiga
I.
,
Floristan
F.
,
Alvarez
C.
,
Odero
M. D.
,
Novo
F. J.
,
Calasanz
M. J.
(
2003
).
t(10;16)(q22;p13) and MORF-CREBBP fusion is a recurrent event in acute myeloid leukemia
.
Genes Chromosomes Cancer
36
,
402
-
405
.
Voss
A. K.
,
Thomas
T.
(
2009
).
MYST family histone acetyltransferases take center stage in stem cells and development
.
BioEssays.
31
,
1050
-
1061
.
Voss
A. K.
,
Krebs
D. L.
,
Thomas
T.
(
2006
).
C3G regulates the size of the cerebral cortex neural precursor population
.
EMBO J.
25
,
3652
-
3663
.
Voss
A. K.
,
Collin
C.
,
Dixon
M. P.
,
Thomas
T.
(
2009
).
Moz and retinoic acid coordinately regulate H3K9 acetylation, Hox gene expression, and segment identity
.
Dev. Cell
17
,
674
-
686
.
Wang
Z.
,
Zang
C.
,
Cui
K.
,
Schones
D. E.
,
Barski
A.
,
Peng
W.
,
Zhao
K.
(
2009
).
Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes
.
Cell
138
,
1019
-
1031
.
Ware
C. B.
,
Wang
L.
,
Mecham
B. H.
,
Shen
L.
,
Nelson
A. M.
,
Bar
M.
,
Lamba
D. A.
,
Dauphin
D. S.
,
Buckingham
B.
,
Askari
B.
, et al. 
. (
2009
).
Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells
.
Cell Stem Cell
4
,
359
-
369
.
Zhao
C.
,
Deng
W.
,
Gage
F. H.
(
2008
).
Mechanisms and functional implications of adult neurogenesis
.
Cell
132
,
645
-
660
.

Supplementary information